Shree Bio-Tech Financials

BSE: 539470

₹0.49

₹0.01 (2.08%)

As on 04-Sep-2026IST

Market cap

₹20 Cr

Revenue (TTM)

₹5 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	5.02	22.96	20.28	62.45	72.64	17.21
Total Income	6.39	24.40	21.33	63.02	72.69	17.21
Total Expenditure	6.78	24.01	20.48	60.30	69.19	16.51
EBITDA	-1.76	-1.05	-0.20	2.15	3.45	0.71
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
EBIT	-1.77	-1.05	-0.20	2.15	3.45	0.71
Interest	--	--	0.00	0.00	0.00	0.00
Other Income	1.38	1.44	1.06	0.56	0.05	--
Exceptional Items	--	--	--	--	--	-0.28
Profit before Tax	-0.39	0.39	0.85	2.71	3.50	0.43
Provision for Tax	--	0.11	0.23	0.68	0.97	0.11
Profit after Tax	-0.39	0.28	0.62	2.04	2.53	0.32

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	63.63	63.26	62.98	62.36	60.32	57.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	0.19
Current Liabilities	0.17	0.23	10.64	17.17	33.24	16.64
Total Liabilities	63.80	63.49	73.62	79.52	93.55	74.63

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	51.90	60.09	69.89	59.68	49.59	46.22
Current Assets	11.90	3.39	3.73	19.84	43.97	28.41
Total Assets	63.80	63.49	73.62	79.52	93.55	74.63
Total Debt*	--	--	--	--	--	0.19
Net Current Assets	11.73	3.16	-6.91	2.68	10.73	11.76
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-10.21	10.16	10.54	3.57	2.36
Cash Flow from Investing Activities	--	9.80	-10.21	-10.09	-3.37	-2.36
Cash from Financing Activities	--	--	--	--	-0.19	--
Net Cash Inflow / Outflow	--	-0.41	-0.05	0.44	0.01	0.01

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.01	0.01	0.02	0.05	0.06	0.01
Cash EPS (₹)	-0.01	0.01	0.02	0.05	0.06	0.01
Adjusted Book Value (₹)	1.58	1.59	1.58	1.56	1.51	1.45
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.26	0.25	0.26	0.18	1.19
Free Cash Flow per Share (₹)	--	-0.26	0.25	0.26	0.18	1.19

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	0.61	1.36	4.43	5.92	0.74
ROE (%)	-0.61	0.44	0.99	3.32	4.28	0.55
ROA (%)	-0.61	0.41	0.81	2.36	3.00	0.45
EBIT Margin (%)	-35.19	-4.59	-0.99	3.44	4.75	4.11
Net Margin (%)	-6.07	1.14	2.91	3.24	3.47	1.84
Cash Profit Margin (%)	0.00	1.21	3.06	3.27	3.48	1.84

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-75.87	13.22	-67.53	-14.03	322.01	596.07
EBIT Growth (%)	-74.75	-423.60	-109.37	-37.68	387.48	199.31
Net Profit Growth (%)	-181.34	-55.15	-69.55	-19.29	697.39	34.31
EPS Growth (%)	-180.83	-55.13	-69.47	-19.40	702.53	33.56
Book Value Growth (%)	--	0.44	1.00	3.38	4.37	0.55

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-50.34	128.57	67.31	19.96	36.70	37.29
Price / Book Value	0.31	0.57	0.66	0.65	3.07	4.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-50.45	92.57	48.42	14.80	52.95	333.77
Close Price (₹)	0.56	0.90	1.05	1.02	4.65	5.93
High Price (₹)	0.88	1.44	1.89	5.63	11.39	7.43
Low Price (₹)	0.52	0.83	0.70	0.85	4.59	4.57
Market Cap (₹ Cr)	19.53	35.88	41.86	40.66	185.36	236.18

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	0.00
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	70.02	14.65	0.35	1.16	1.32	1.71
Quick Ratio	1.01	2.18	0.35	1.16	1.32	1.71
Interest Coverage	--	--	8,550.00	--	--	1,072.24

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	--	--	16.29	30.95	60.42	164.63
Asset Turnover	0.08	0.33	0.26	0.72	0.86	0.25
Receivable days	--	--	203.69	184.73	181.46	520.89
Inventory Days	--	45.95	--	--	--	--
Payable days	--	--	244.63	149.35	129.48	263.54
Cash Conversion Cycle	--	--	-40.94	35.38	51.98	257.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.